MTIP AG

APRICITY is the world's first virtual fertility clinic. It aims at disrupting the fertility treatment experience and at improving chances for women and couples who have difficulties to conceive using data and Artificial Intelligence. The project is led by prominent entrepreneurs, medical practitioners, committed executives and data scientists with a proven track record.

LynxCare is an AI-powered Big Data platform. We enable hospitals to mine their legacy data, to improve clinical efficiency and higher the quality of care.

Mediktor is the most advanced and accurate expert system for pre-diagnoses, triage and decision-making support. The first artificial intelligent system clinically validated that is transforming healthcare for everyone. A technology that finally makes it possible to reduce access barriers to healthcare: - Patients can make better decisions from the first symptoms - And the healthcare system can organize its demand and optimize resources to offer a better medical coverage.

Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform. They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions. Oviva was founded in 2013 and is based in London, England.

Intelligencia AI is an enterprise SaaS company that specializes in applying machine learning technology to enhance clinical development strategies. The company has developed a cloud-based platform that utilizes predictive analytics to assess, quantify, and mitigate risks associated with clinical trials. By estimating the probability of success for various trial designs, Intelligencia's platform allows healthcare organizations to optimize their approaches before initiating trials. This proactive risk management not only helps to save time and resources for clinical trials but also facilitates quicker access to innovative therapies for patients.

Koa Health is digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies. It delivers mental health support that is accessible, personalized, and effective across a range of conditions. The company's other products include Mindset, offered through providers as a way to facilitate private chat-based mental health support. They create digital tools and resources for mental health that encompass prevention, prediction, and treatment. It offers a library of evidence-based activities for tackling stress, sleeping better, aiding relaxation and positive thinking, and boosting self-confidence.

Lumeon is a digital health company that has defined the market for Care Pathway Management (CPM). From scheduling and revenue management to clinical reporting and aftercare, by looking across the end-to end care pathway, Lumeon addresses the system, and not just the symptom, behind healthcare transformation. Lumeon's customers number among Europe’s fastest growing and most innovative healthcare providers including BUPA, Nuffield Health, Alliance Medical, HCA, Optegra and Newmedica. It is headquartered in London employing over 90 people.

Trialbee is an independent software company dedicated to deliver solutions and services to the pharmaceutical industry. The company was founded in 2010 with the development of a method to increase speed and accuracy of patient recruitment to clinical trials.

Oviva is digitizing the treatment of type 2 diabetes and obesity through a unique behavior change platform. They have developed unique, personalised behaviour change programmes that combine smartphone app and learning portals to support dietitian-led behaviour change for conditions such as type 2 diabetes and complex obesity. Their approach allows patients to achieve a better health outcome without having to attend clinic appointments, whilst saving health systems significant sums by preventing the development of complications related to these health conditions. Oviva was founded in 2013 and is based in London, England.

Lumeon is a digital health company that has defined the market for Care Pathway Management (CPM). From scheduling and revenue management to clinical reporting and aftercare, by looking across the end-to end care pathway, Lumeon addresses the system, and not just the symptom, behind healthcare transformation. Lumeon's customers number among Europe’s fastest growing and most innovative healthcare providers including BUPA, Nuffield Health, Alliance Medical, HCA, Optegra and Newmedica. It is headquartered in London employing over 90 people.

Nitinotes has developed the EndoZip™, a fully automated, gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction to help obese patients reduce weight.

Nitinotes has developed the EndoZip™, a fully automated, gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction to help obese patients reduce weight.

TytoCare is a mobile-health platform and device, that allows anyone to perform self-physical examination and remote diagnosis. Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit and include a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use.

Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for the successful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.

Blueprint Genetics provides genetic diagnostics of rare diseases based on Next-Generation Sequencing (NGS). The professional genetic tests are targeted for hospitals and research groups. Blueprint Genetics aims to disrupt the market by decreasing the price level of genetic diagnostics significantly while increasing quality and adding clinical insight to the results statements. The tests are based on a novel NGS method called OS-Seq:tm: that was developed in the Stanford University. The product roadmap of the company covers a long list of diagnostics for different hereditary diseases. The currently available products cover relevant rare hereditary cardiovascular diseases, such as cardiomyopathies, arrhythmias and aorta diseases. The company is based in Helsinki, Finland and has an office also in Los Angeles, CA.

Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for the successful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.